Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: HER-2/neu intracellular domain protein|OTHER: flow cytometry|OTHER: immunohistochemistry staining method|PROCEDURE: biopsy|OTHER: Sterile water placement
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)